Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

Sep 06 2010

• By The Pink Sheet

Related Content

CAP Drugs Must Meet Stricter Noninferiority Criteria Under Draft FDA Guidance

Jun 08 2009

Theravance Gets To Market With Vibativ, But HAP Indication Could Be Pushed To 2010

Sep 14 2009

Advisory Committee Splits The Difference On CABP Trials

Dec 21 2009

Regulatory News, In Brief

Aug 30 2010

Industry’s Lesson On Non-Inferiority Margins In Anti-Infective Trials: Use 10%

Nov 24 2008

Antibiotic Development: FDA Says New Guidances Will Help, But Industry Questions Statistical Focus

Jun 28 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window